A new module in neural differentiation control: Two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Annibali, Daniela ^a,b   Gioia, Ubaldo ^a   Savino, Mauro ^a   Laneve, Pietro ^a,c   Caffarelli, Elisa ^a   Nasi, Sergio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Vesalius Research Center   (Belgium)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF DIFFERENTIATION 2; MESSENGER RNA; MICRORNA; MICRORNA 103; MICRORNA 9; MYC PROTEIN; NEUROFILAMENT PROTEIN; NEUROFILAMENT PROTEIN 200; PROTEIN PRECURSOR; PROTEIN VGF; RETINOIC ACID; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; BIOINFORMATICS; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; MOUSE; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REGULATORY MECHANISM; SEQUENCE ALIGNMENT; UPREGULATION; WILD TYPE;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; MACACA MULATTA; MICE; MICRORNAS; NEOPLASM PROTEINS; NEUROBLASTOMA; RATS; RNA, NEOPLASM; TRETINOIN; UP-REGULATION;

EID: 84864355820     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040269     Document Type: Article

References (66)

1. Ruzinova MB, Benezra R, (2003) Id proteins in development, cell cycle and cancer. Trends Cell Biol 13: 410-418.
2. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, et al. (2001) Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409: 1067-1070.
3. Roberts EC, Deed RW, Inoue T, Norton JD, Sharrocks AD, (2001) Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding. Mol Cell Biol 21: 524-533.
4. Chassot AA, Turchi L, Virolle T, Fitsialos G, Batoz M, et al. (2007) Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progression. Oncogene 26: 5772-5783.
5. Iavarone A, Garg P, Lasorella A, Hsu J, Israel MA, (1994) The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev 8: 1270-1284.
6. Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A, (2000) Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 407: 592-598.
7. Jogi A, Persson P, Grynfeld A, Pahlman S, Axelson H, (2002) Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation. J Biol Chem 277: 9118-9126.
8. Vandeputte DA, Troost D, Leenstra S, Ijlst-Keizers H, Ramkema M, et al. (2002) Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors. Glia 38: 329-338.
9. Perk J, Iavarone A, Benezra R, (2005) Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 5: 603-614.
10. Iavarone A, Lasorella A, (2006) ID proteins as targets in cancer and tools in neurobiology. Trends Mol Med 12: 588-594.
11. Henke E, Perk J, Vider J, de Candia P, Chin Y, et al. (2008) Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo. Nat Biotechnol 26: 91-100.
12. Martinsen BJ, Bronner-Fraser M, (1998) Neural crest specification regulated by the helix-loop-helix repressor Id2. Science 281: 988-991.
13. Bai G, Sheng N, Xie Z, Bian W, Yokota Y, et al. (2007) Id sustains Hes1 expression to inhibit precocious neurogenesis by releasing negative autoregulation of Hes1. Dev Cell 13: 283-297.
14. Zhang C, Zhang Z, Shu H, Liu S, Song Y, et al. (2010) The modulatory effects of bHLH transcription factors with the Wnt/beta-catenin pathway on differentiation of neural progenitor cells derived from neonatal mouse anterior subventricular zone. Brain Res 1315: 1-10.
15. Havrda MC, Harris BT, Mantani A, Ward NM, Paolella BR, et al. (2008) Id2 is required for specification of dopaminergic neurons during adult olfactory neurogenesis. J Neurosci 28: 14074-14086.
16. Paolella BR, Havrda MC, Mantani A, Wray CM, Zhang Z, et al. (2011) p53 directly represses Id2 to inhibit the proliferation of neural progenitor cells. Stem Cells 29: 1090-1101.
17. Coma S, Amin DN, Shimizu A, Lasorella A, Iavarone A, et al. (2010) Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F. Cancer Res 70: 3823-3832.
18. Brodeur GM, (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216.
19. Lasorella A, Iavarone A, (2006) The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system. Proc Natl Acad Sci U S A 103: 4976-4981.
20. Lopez-Carballo G, Moreno L, Masia S, Perez P, Barettino D, (2002) Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem 277: 25297-25304.
21. Yao W, Qian W, Zhu C, Gui L, Qiu J, et al. (2010) Cdh1-APC is involved in the differentiation of neural stem cells into neurons. Neuroreport 21: 39-44.
22. Ciarapica R, Annibali D, Raimondi L, Savino M, Nasi S, et al. (2009) Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation. Oncogene 28: 1881-1891.
23. Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, et al. (2009) Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J Clin Oncol 27: 1007-1013.
24. Wu N, Castel D, Debily MA, Vigano MA, Alibert O, et al. (2011) Large scale RNAi screen reveals that the Inhibitor of DNA binding 2 (ID2) protein is repressed by p53 family member p63 and functions in human keratinocyte differentiation. J Biol Chem.
25. Ying QL, Nichols J, Chambers I, Smith A, (2003) BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115: 281-292.
26. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
27. Kasinski AL, Slack FJ, (2011) MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 11: 849-864.
28. Krichevsky AM, Sonntag KC, Isacson O, Kosik KS, (2006) Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells 24: 857-864.
29. Laneve P, Di Marcotullio L, Gioia U, Fiori ME, Ferretti E, et al. (2007) The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells. Proc Natl Acad Sci U S A 104: 7957-7962.
30. Zhao C, Sun G, Li S, Shi Y, (2009) A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat Struct Mol Biol 16: 365-371.
31. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, et al. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129-141.
32. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, et al. (2006) A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126: 1203-1217.
33. Yuva-Aydemir Y, Simkin A, Gascon E, Gao FB, (2011) MicroRNA-9: Functional evolution of a conserved small regulatory RNA. RNA Biol 8: 557-564.
34. Schoenherr CJ, Anderson DJ, (1995) The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science 267: 1360-1363.
35. Laneve P, Gioia U, Andriotto A, Moretti F, Bozzoni I, et al. (2010) A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation. Nucleic Acids Res 38: 6895-6905.
36. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, et al. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256.
37. Hoesel B, Bhujabal Z, Przemeck GK, Kurz-Drexler A, Weisenhorn DM, et al. (2010) Combination of in silico and in situ hybridisation approaches to identify potential Dll1 associated miRNAs during mouse embryogenesis. Gene Expr Patterns 10: 265-273.
38. Favereaux A, Thoumine O, Bouali-Benazzouz R, Roques V, Papon MA, et al. (2011) Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain. EMBO J 30: 3830-3841.
39. Rottiers V, Naar AM, (2012) MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 13: 1.
40. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS, (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38: 3751-3757.
41. Schwab M, (2004) MYCN in neuronal tumours. Cancer Lett 204: 179-187.
42. Tweddle DA, Malcolm AJ, Cole M, Pearson AD, Lunec J, (2001) p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells. Am J Pathol 158: 2067-2077.
43. Filipowicz W, Bhattacharyya SN, Sonenberg N, (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114.
44. Thiele CJ, Reynolds CP, Israel MA, (1985) Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313: 404-406.
45. Di Rocco G, Pennuto M, Illi B, Canu N, Filocamo G, et al. (1997) Interplay of the E box, the cyclic AMP response element, and HTF4/HEB in transcriptional regulation of the neurospecific, neurotrophin-inducible vgf gene. Mol Cell Biol 17: 1244-1253.
46. Nagasaki K, Sasaki K, Maass N, Tsukada T, Hanzawa H, et al. (1999) Staurosporine enhances cAMP-induced expression of neural-specific gene VGF and tyrosine hydroxylase. Neurosci Lett 267: 177-180.
47. Rossi A, Granata F, Augusti-Tocco G, Canu N, Levi A, et al. (1992) Expression in murine and human neuroblastoma cell lines of VGF, a tissue specific protein. Int J Dev Neurosci 10: 527-534.
48. Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA, (1989) Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 49: 219-225.
49. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS, (2003) A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9: 1274-1281.
50. Easow G, Teleman AA, Cohen SM, (2007) Isolation of microRNA targets by miRNP immunopurification. RNA 13: 1198-1204.
51. Forman JJ, Coller HA, (2010) The code within the code: microRNAs target coding regions. Cell Cycle 9: 1533-1541.
52. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
53. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I, (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124-1128.
54. Fang Z, Rajewsky N, (2011) The impact of miRNA target sites in coding sequences and in 3′UTRs. PLoS One 6: e18067.
55. Yoo AS, Sun AX, Li L, Shcheglovitov A, Portmann T, et al. (2011) MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 476: 228-231.
56. Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL, (2008) The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci 28: 14341-14346.
57. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP, (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146: 353-358.
58. Liao Y, Lonnerdal B, (2010) Global microRNA characterization reveals that miR-103 is involved in IGF-1 stimulated mouse intestinal cell proliferation. PLoS One 5: e12976.
59. Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, et al. (2010) A MicroRNA targeting dicer for metastasis control. Cell 141: 1195-1207.
60. Itahana Y, Singh J, Sumida T, Coppe JP, Parrinello S, et al. (2003) Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells. Cancer Res 63: 7098-7105.
61. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, et al. (2008) A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 105: 13556-13561.
62. Ferretti E, De Smaele E, Po A, Di Marcotullio L, Tosi E, et al. (2009) MicroRNA profiling in human medulloblastoma. Int J Cancer 124: 568-577.
63. Ben-Hamo R, Efroni S, (2011) Gene-expression and network-based analysis reveals a novel role for hsa-mir-9 and drug control over the p38 network in Glioblastoma Multiforme progression. Genome Med 3: 77.
64. Kim TM, Huang W, Park R, Park PJ, Johnson MD, (2011) A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. Cancer Res 71: 3387-3399.
65. Pear WS, Nolan GP, Scott ML, Baltimore D, (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 90: 8392-8396.
66. Bonci D, Cittadini A, Latronico MV, Borello U, Aycock JK, et al. (2003) 'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. Gene Ther 10: 630-636.